Skip to content
OpenCapital
Get started

LivaNova LIVN Increase (Decrease) in Inventories

Increase (Decrease) in Inventories at other companies

Baxter International logo
Baxter InternationalBAX
$95M-22.1%
Haemonetics logo
HaemoneticsHAE
——
Medtronic logo
MedtronicMDT
——
ResMed logo
ResMedRMD
——
Merit Medical Systems logo
Merit Medical SystemsMMSI
——
Globus Medical logo
Globus MedicalGMED
——

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.31B+62.8%
Enterprise value$4.11B+58.0%
P/S3×+0.9×

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's increase (decrease) in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's increase (decrease) in inventories?
LivaNova (LIVN) reported increase (decrease) in inventories of $1.55M in Q1 2026.
How has LivaNova's increase (decrease) in inventories changed year-over-year?
LivaNova's increase (decrease) in inventories decreased by 38.0% year-over-year, from $2.49M to $1.55M.
What does increase (decrease) in inventories mean?
Represents the net change in the value of raw materials, work-in-progress, and finished goods held by the company. This metric reflects inventory management strategy, such as building stock for anticipated demand or clearing excess supply. It is a fundamental component of operating cash flow analysis and supply chain efficiency.